MACUGEN

Welcome to the Brand page for “MACUGEN”, which is offered here for In the statement, column 1, line 2, 666 fifth avenue, 35th floor should be deleted, and, two times square should be inserted.;pharmaceutical composition, a pharmaceutical composition for treatment of age-related macular degeneration, diabetic macular edema, and other retinal diseases in the back of the eye;.

Its status is currently believed to be active. Its class is unavailable. “MACUGEN” is believed to be currently owned by “BAUSCH + LOMB IRELAND LIMITED”.


Owner:
BAUSCH + LOMB IRELAND LIMITED
Owner Details
Description:
In the statement, column 1, line 2, 666 FIFTH AVENUE, 35TH FLOOR should be deleted, and, TWO TIMES SQUARE should be inserted.;pharmaceutical composition, a pharmaceutical composition for treatment of age-related macular degeneration, diabetic macular edema, and other retinal diseases in the back of the eye;
Categories: STATEMENT